drugset / Trial / NCT03566316
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-blind, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine and Rosuvastatin Co-administration in Hypertensive Patients with Hyperlipidemia
Timeline
- Start
- 2015-11-24
- Primary completion
- 2017-06-16
- Completion
- 2017-06-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Rosuvastatin | Small molecule | 80 mg | — |
| Comparator | Telmisartan | Other / unclassified | 20 mg | — |
| Comparator | Telmisartan | Other / unclassified | 80 mg | — |